MY133842A - Sodium-hydrogen exchanger type 1 inhibitor. - Google Patents

Sodium-hydrogen exchanger type 1 inhibitor.

Info

Publication number: MY133842A
Authority: MY; Malaysia
Prior art keywords: inhibitor; sodium; exchanger type; hydrogen exchanger; nhe
Prior art date: 2000-04-28

Application number

MYPI20011977A

Other languages

English (en)

Inventor

Guzman-Perez Angel

David Cox Eric

George Chen Weichao

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-04-28

Filing date

2001-04-26

Publication date

2007-11-30

2001-04-26 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2007-11-30 Publication of MY133842A publication Critical patent/MY133842A/en

Links

239000003112 inhibitor Substances 0.000 title abstract 5
102000052126 Sodium-Hydrogen Exchangers Human genes 0.000 title 1
108091006672 Sodium–hydrogen antiporter Proteins 0.000 title 1
102100030980 Sodium/hydrogen exchanger 1 Human genes 0.000 abstract 4
108010093115 growth factor-activatable Na-H exchanger NHE-1 Proteins 0.000 abstract 4
208000028867 ischemia Diseases 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Treatment Of Water By Ion Exchange (AREA)
Preventing Corrosion Or Incrustation Of Metals (AREA)
Plural Heterocyclic Compounds (AREA)

MYPI20011977A 2000-04-28 2001-04-26 Sodium-hydrogen exchanger type 1 inhibitor. MY133842A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US20043200P	2000-04-28	2000-04-28

Publications (1)

Publication Number	Publication Date
MY133842A true MY133842A (en)	2007-11-30

Family

ID=22741697

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MYPI20011977A MY133842A (en)	2000-04-28	2001-04-26	Sodium-hydrogen exchanger type 1 inhibitor.

Country Status (40)

Country	Link
EP (1)	EP1276737A1 (is)
JP (1)	JP2003531900A (is)
KR (1)	KR20020093079A (is)
CN (1)	CN1225466C (is)
AP (1)	AP2002002651A0 (is)
AR (1)	AR028375A1 (is)
AU (1)	AU2001235896A1 (is)
BG (1)	BG107139A (is)
BR (1)	BR0110268A (is)
CA (1)	CA2407535A1 (is)
CO (1)	CO5221125A1 (is)
CR (1)	CR6797A (is)
CZ (1)	CZ20023408A3 (is)
DZ (1)	DZ3310A1 (is)
EA (1)	EA004882B1 (is)
EE (1)	EE200200615A (is)
GT (1)	GT200100064A (is)
HN (1)	HN2001000042A (is)
HR (1)	HRP20020851A2 (is)
HU (1)	HUP0300651A2 (is)
IL (1)	IL152075A0 (is)
IS (2)	IS6567A (is)
MA (1)	MA26897A1 (is)
MX (1)	MXPA02010600A (is)
MY (1)	MY133842A (is)
NO (1)	NO20025132L (is)
NZ (1)	NZ521348A (is)
OA (1)	OA12256A (is)
PA (1)	PA8513301A1 (is)
PE (1)	PE20011270A1 (is)
PL (1)	PL357765A1 (is)
SK (1)	SK14872002A3 (is)
SV (1)	SV2002000418A (is)
TN (1)	TNSN01065A1 (is)
TR (1)	TR200202439T2 (is)
UA (1)	UA73348C2 (is)
UY (1)	UY26680A1 (is)
WO (1)	WO2001083470A1 (is)
YU (1)	YU79602A (is)
ZA (1)	ZA200208605B (is)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2436539A1 (en) *	2001-01-31	2002-08-08	Pfizer Products Inc.	Ethanolates of sodium-hydrogen exchanger type-1 inhibitor
BR0215002A (pt) *	2001-12-19	2004-11-09	Pfizer Prod Inc	Métodos de preparação de inibidores de permutadores de sódio-hidrogênio de tipo 1
CA2483927A1 (en) *	2002-05-02	2003-11-13	Pfizer Products Inc.	Treatment of diabetes and diabetic complications with nhe-1 inhibitors
FR2840302B1 (fr) *	2002-06-03	2004-07-16	Aventis Pharma Sa	Derives d'isoindolones, procede de preparation et intermediaire de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
ES2220185B1 (es) *	2002-07-16	2006-04-01	Consejo Sup. De Investig. Cientificas	Nuevo peptido inhibidor del intercambiador na+/h+ (pinhe), y sus aplicaciones.
US7550480B2 (en) *	2003-02-14	2009-06-23	Smithkline Beecham Corporation	Compounds
RU2518741C1 (ru) *	2013-03-22	2014-06-10	Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ"	СРЕДСТВО, ИНГИБИРУЮЩЕЕ Na+/H+-ОБМЕН, И ГАЛОГЕНИДЫ 1-ДИАЛКИЛАМИНОЭТИЛ-3-[ЗАМЕЩЕННЫЙ(ДИЗАМЕЩЕННЫЙ) ФЕНАЦИЛ]-2-АМИНОБЕНЗИМИДАЗОЛИЯ

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2002504546A (ja) *	1998-02-27	2002-02-12	ファイザー・プロダクツ・インク	虚血の治療のためのｎ−［（置換５員ジもしくはトリアザ二不飽和環）カルボニル］グアニジン誘導体

2001
- 2001-02-28 AP APAP/P/2002/002651A patent/AP2002002651A0/en unknown
- 2001-02-28 OA OA1200200331A patent/OA12256A/en unknown
- 2001-02-28 HU HU0300651A patent/HUP0300651A2/hu unknown
- 2001-02-28 KR KR1020027014355A patent/KR20020093079A/ko not_active Abandoned
- 2001-02-28 EP EP01908037A patent/EP1276737A1/en not_active Withdrawn
- 2001-02-28 YU YUP-796/02A patent/YU79602A/sh unknown
- 2001-02-28 UA UA2002108497A patent/UA73348C2/uk unknown
- 2001-02-28 CZ CZ20023408A patent/CZ20023408A3/cs unknown
- 2001-02-28 HR HR20020851A patent/HRP20020851A2/hr not_active Application Discontinuation
- 2001-02-28 IL IL15207501A patent/IL152075A0/xx unknown
- 2001-02-28 EE EEP200200615A patent/EE200200615A/xx unknown
- 2001-02-28 CA CA002407535A patent/CA2407535A1/en not_active Abandoned
- 2001-02-28 AU AU2001235896A patent/AU2001235896A1/en not_active Abandoned
- 2001-02-28 CN CNB018087256A patent/CN1225466C/zh not_active Expired - Fee Related
- 2001-02-28 TR TR2002/02439T patent/TR200202439T2/xx unknown
- 2001-02-28 SK SK1487-2002A patent/SK14872002A3/sk unknown
- 2001-02-28 PL PL01357765A patent/PL357765A1/xx not_active Application Discontinuation
- 2001-02-28 MX MXPA02010600A patent/MXPA02010600A/es active IP Right Grant
- 2001-02-28 EA EA200201023A patent/EA004882B1/ru not_active IP Right Cessation
- 2001-02-28 BR BR0110268-0A patent/BR0110268A/pt not_active IP Right Cessation
- 2001-02-28 WO PCT/IB2001/000277 patent/WO2001083470A1/en not_active Ceased
- 2001-02-28 NZ NZ521348A patent/NZ521348A/en unknown
- 2001-02-28 JP JP2001580898A patent/JP2003531900A/ja active Pending
- 2001-02-28 DZ DZ013310A patent/DZ3310A1/fr active
- 2001-03-06 HN HN2001000042A patent/HN2001000042A/es unknown
- 2001-03-12 PA PA20018513301A patent/PA8513301A1/es unknown
- 2001-04-20 GT GT200100064A patent/GT200100064A/es unknown
- 2001-04-24 UY UY26680A patent/UY26680A1/es not_active Application Discontinuation
- 2001-04-26 MY MYPI20011977A patent/MY133842A/en unknown
- 2001-04-26 PE PE2001000376A patent/PE20011270A1/es not_active Application Discontinuation
- 2001-04-26 AR ARP010101970A patent/AR028375A1/es unknown
- 2001-04-27 SV SV2001000418A patent/SV2002000418A/es not_active Application Discontinuation
- 2001-04-27 TN TNTNSN01065A patent/TNSN01065A1/fr unknown
- 2001-04-27 CO CO01032977A patent/CO5221125A1/es not_active Application Discontinuation
2002
- 2002-09-23 BG BG107139A patent/BG107139A/bg unknown
- 2002-09-24 IS IS6567A patent/IS6567A/is unknown
- 2002-10-18 CR CR6797A patent/CR6797A/es not_active Application Discontinuation
- 2002-10-18 MA MA26875A patent/MA26897A1/fr unknown
- 2002-10-21 IS IS6588A patent/IS6588A/is unknown
- 2002-10-24 ZA ZA200208605A patent/ZA200208605B/en unknown
- 2002-10-25 NO NO20025132A patent/NO20025132L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
CN1225466C (zh)	2005-11-02
TNSN01065A1 (fr)	2005-11-10
GT200100064A (es)	2002-03-22
CO5221125A1 (es)	2002-11-28
WO2001083470A1 (en)	2001-11-08
EE200200615A (et)	2004-04-15
IL152075A0 (en)	2003-05-29
CA2407535A1 (en)	2001-11-08
HN2001000042A (es)	2001-07-09
NZ521348A (en)	2004-09-24
NO20025132L (no)	2002-12-12
ZA200208605B (en)	2003-10-24
CR6797A (es)	2004-05-17
TR200202439T2 (tr)	2003-02-21
IS6588A (is)	2002-10-21
AR028375A1 (es)	2003-05-07
HRP20020851A2 (en)	2005-02-28
EA004882B1 (ru)	2004-08-26
HUP0300651A2 (hu)	2003-07-28
UA73348C2 (en)	2005-07-15
KR20020093079A (ko)	2002-12-12
IS6567A (is)	2002-09-24
OA12256A (en)	2003-11-06
AU2001235896A1 (en)	2001-11-12
BR0110268A (pt)	2003-12-30
BG107139A (bg)	2003-07-31
SV2002000418A (es)	2002-07-03
CN1426404A (zh)	2003-06-25
MXPA02010600A (es)	2003-03-10
DZ3310A1 (fr)	2001-11-07
EP1276737A1 (en)	2003-01-22
UY26680A1 (es)	2001-12-28
MA26897A1 (fr)	2004-12-20
YU79602A (en)	2006-05-25
PL357765A1 (en)	2004-07-26
JP2003531900A (ja)	2003-10-28
PE20011270A1 (es)	2001-12-12
SK14872002A3 (sk)	2004-03-02
NO20025132D0 (no)	2002-10-25
CZ20023408A3 (cs)	2004-01-14
PA8513301A1 (es)	2003-09-05
AP2002002651A0 (en)	2002-12-31
EA200201023A1 (ru)	2003-02-27

Publication	Publication Date	Title
CA2260337A1 (en)	1999-07-27	Therapeutic agents
BR0110101A (pt)	2005-06-07	N-acil-sulfonamidas promotoras de apoptose
SK86699A3 (en)	2000-11-07	Nitrogen containing heteroaromatics as factor xa inhibitors
AP9901478A0 (en)	1999-03-31	Compounds for the treatment of ischemia.
HRP20000292B1 (hr)	2008-09-30	2-fenil supstituirani imidazotriazinoni kao inhibitori fosfodiesteraze
BG105369A (en)	2001-12-29	Arylpiperazines and their use as metalloproteinase inhibiting agent (mmp
BG106585A (en)	2003-03-31	Kinase inhibitors as therapeutic agents
ATE218859T1 (de)	2002-06-15	Liganden des neuropeptids y
MXPA02009706A (es)	2004-09-06	Metodo para sintesis de perindopril y sus sales farmaceuticamente aceptables.
GB9929552D0 (en)	2000-02-09	Compounds
GB0114185D0 (en)	2001-08-01	Compounds
NO20010331L (no)	2001-03-20	Ftalazinderivater som fosfodiesterase 4-inhibitorer
RU2001126719A (ru)	2004-02-20	Дигетерозамещенные ингибиторы металлопротеазы
WO2000005214A3 (en)	2001-05-31	Isoquinolines as urokinase inhibitors
TR200201128T2 (tr)	2002-08-21	PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri.
CA2412596A1 (en)	2002-01-03	Cyclic gmp-specific phosphodiesterase inhibitors
BG104575A (en)	2001-02-28	Matrix metalloprotease inhibitors
AU2001276027A1 (en)	2002-02-05	Heteroaryl-beta-alanine derivatives as alpha 4 integrin inhibitors
MY133842A (en)	2007-11-30	Sodium-hydrogen exchanger type 1 inhibitor.
DK1204659T3 (da)	2004-04-05	Serotonerge benzofuraner
SI1377574T1 (is)	2005-08-31
GB2324091A (en)	1998-10-14	Metalloproteinase inhibitors
HRP20010885B1 (en)	2010-07-31	Ethanesulfonyl-piperidine derivatives
DE60116514D1 (de)	2006-03-30	Amlodipin-hemimaleat
AP2002002493A0 (en)	2002-06-30	Sodium-hydrogen exchanger type 1 inhibitor crystals.